Difference between revisions of "Team:Montpellier/Description"
MariePeras (Talk | contribs) |
MariePeras (Talk | contribs) |
||
| Line 46: | Line 46: | ||
<tr> | <tr> | ||
<td>YLP20</td> | <td>YLP20</td> | ||
| − | <td> | + | <td>Antibody</td> |
<td>Homo sapiens</td> | <td>Homo sapiens</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>AS16</td> | <td>AS16</td> | ||
| − | <td> | + | <td>Antibody</td> |
<td>Homo sapiens</td> | <td>Homo sapiens</td> | ||
</tr> | </tr> | ||
Revision as of 16:13, 27 June 2018
Description
To achieve our goal, we want to design a L.jensenii with a spermicidal effect which can allow a long term contraception for women. We are focusing on different types of spermidical molecules :
| Name | Type of molecule | Origin |
|---|---|---|
| Nisin | Lantipeptid | Lactococcus lactis |
| Lacticin 3147 | Lantipeptid | Lactococcus lactis |
| Subtilosin A | Sactipeptid | Bacillus subtilis |
| Magainin II | Magainin | Xenopus laevis |
| LL37 | Cathelicidin antimicrobial peptid | Homo sapiens |
| YLP20 | Antibody | Homo sapiens |
| AS16 | Antibody | Homo sapiens |